Chinese vaccine diplomacy has been slipping in recent months. The lack of effectiveness of “made in China” serums against the Delta variant has brutally slowed down the enthusiasm of many southern countries. Malaysia announced in mid-July that it was stopping the use of Sinovac due to concerns about its effectiveness. In Indonesia, the country that bought the most doses from China (211 million), the death of 131 caregivers this summer, vaccinated with Sinovac, has caused great concern. The Moderna vaccine is now given as a booster to caregivers. Thailand has also halted its purchases of Chinese vaccines, becoming the first country to offer a dose of AstraZeneca to those who had already received one or two injections of Sinovac. The country will soon be followed by Cambodia, yet a great ally of China. After purchasing 100 million doses from Sinovac,Turkey has fallen back on Pfizer from whom it has ordered 120 million vaccines.
Covid-19: the noose is tightening around the unvaccinated in China
This turnaround is reflected in the figures of
This article is for subscribers only.
You have 70% left to discover.
To cultivate your freedom is to cultivate your curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT